Aids vaccine protects trial volunteers.Summary: An experimental AIDS vaccine AIDS vaccine A hypothetical vaccine intended to either prevent HIV infection or ensure that those infected will not fall victim to AIDS; the most promising vaccine is that using a naked DNA plasmid, reported by Letwin et al in 20/10/00 Science; as of early 2001, , made using two older vaccines, has protected volunteers in a study in Thailand. An experimental AIDS vaccine, made using two older vaccines, has protected volunteers in a study in Thailand. U.S. and Thai researchers have reported a lowering of the risk of infection by about a third. The vaccine is a combination of Sanofi-Aventis' ALVAC canary pox pox (poks) any eruptive or pustular disease, especially one caused by a virus, e.g., chickenpox, cowpox, etc. pox n. 1. vaccine and the failed HIV vaccine HIV vaccine AIDS As of mid-2005, there is no viable anti-HIV vaccine. See AIDS. AIDSVAX, which was made by VaxGen and is now owned by the non-profit organisation, Global Solutions for Infectious Diseases infectious diseases: see communicable diseases. . The researchers, from America and Thailand, said that the new vaccine lowered the risk of HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. infection by 32 per cent among 16,000 heterosexual Thai volunteers who had no special risk of AIDS infection. Independent Television News Limited 2009. All rights reserved. Independent Television News Limited 2009. All rights reserved. Provided by Syndigate.info an Albawaba.com company |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion